The risk factors for venous thrombosis differ from those for arterial vascular disease. During
the past 5 years, knowledge about the aetiology of venous thrombosis has advanced with …

By the use of a fluorogenic thrombin substrate and continuous calibration of each individual
sample, it is now possible to obtain a thrombin generation (TG) curve (or thrombogram) in …

Calibrated automated thrombography displays the concentration of thrombin in clotting
plasma with or without platelets (platelet-rich plasma/platelet-poor plasma, PRP/PPP) in up …

Objective To assess the effect on hemostasis parameters of a new combined oral
contraceptive (COC). Study design In this randomized, single centre, open-label, exploratory …

In the early 1960s, shortly after the introduction of oral contraceptives, the first case reports
appeared describing venous thrombosis and pulmonary emboli in women using this method …

Venous thrombosis occurs in about 1 per 1,000 individuals per year. 1, 2 It usually affects
the deep veins of the leg, but may occur in other sites, such as the upper extremities …

Despite an overall reduction in the death rate due to cardiovascular disease (CVD) in the
United States over the last several decades, the rate of decline is less for women than men …

The development of thrombotic disorders in humans is one of the most common causes of
morbidity and mortality in the Western world. Thrombotic disease can be classified in broad …

Objective: To investigate psychiatric and neurological morbidity, diagnostic stability, and
indicators of prognosis in patients previously identified as having medically unexplained …

The use of oral contraceptives (OC) is a well established risk factor for venous thrombosis. It
has been known for many years that almost all haemostatic parameters ie plasma levels of …